420 Investor Weekly Review 12/23/22


Canada reported October cannabis sales of C$389 million, up 9.5% from a year ago and the slowest annual growth to date.

I distributed this written material to 420 Investor subscribers during the week:

Here are some of this week's highlights for Focus List names:

  • CRON announced that Altria relinquished the out-of-the-money warrant to take control of the company, a move that permitted Altria to take a big tax-loss ($483 million).
  • CURLF opened its 55th Florida medical cannabis dispensary.
  • CWBHF named a new CFO.
  • TCNNF closed two debt securities, one for $71.5 million and the other for $18.9 million. It also announced a settlement with OSHA in Massachusetts.
  • TRSSF reduced its debt by $35 million, paying down its Pennsylvania credit agreement.
  • UGRO announced Good Lettuce Company in New Jersey as a new cannabis client.
  • VRNOF opened its 62nd Florida medical cannabis dispensary.

Please check the Focus List, (which has technical, fundamental and valuation ratings as well as a market-cap table). To help track market caps, we maintain tables for the Canadian LPs and the American cannabis operators and ancillary companies.

There were comments in over 80 discussions in the Forum. Don't miss out on this most informative part of 420 Investor! Not familiar with the the Forum? This video will help! This is a great way to track your favorite tickers, even those not on the Focus List, and to get your questions answered quickly.

Market Performance

The Global Cannabis Stock Index posted a new all-time closing low of 9.55 on Thursday and a new intraday low of 9.40. It was slammed lower this week to 9.71, ending down 11.9% for the week. This was a lot worse than the 0.2% loss in the S&P 500, which is down 5.8% in December. The cannabis index has dropped 29.0% in December, and it has declined 13.8% thus far in Q4. This is worse than the +7.2% return in the S&P 500.

Posted to Benzinga PotProfits on Dec 26, 2022 — 9:12 AM
Comments on this post have been disabled by the Maven.